200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 78281-02-4

78281-02-4

78281-02-4 | 2,5-Cyclohexadien-1-one, 2,4-di-β-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-

CAS No: 78281-02-4 Catalog No: AG001DO1 MDL No:MFCD08435942

Product Description

Catalog Number:
AG001DO1
Chemical Name:
2,5-Cyclohexadien-1-one, 2,4-di-β-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-
CAS Number:
78281-02-4
Molecular Formula:
C27H32O16
Molecular Weight:
612.5334
MDL Number:
MFCD08435942
IUPAC Name:
(6E)-2,5-dihydroxy-6-[(E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-2,4-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione
InChI:
InChI=1S/C27H32O16/c28-7-12-16(32)19(35)21(37)23(42-12)15-18(34)14(11(31)6-3-9-1-4-10(30)5-2-9)24(39)27(41,25(15)40)26-22(38)20(36)17(33)13(8-29)43-26/h1-6,12-13,16-17,19-23,26,28-38,41H,7-8H2/b6-3+,14-11+/t12-,13-,16-,17-,19+,20+,21-,22-,23+,26-,27?/m1/s1
InChI Key:
IAVUBSCVWHLRGE-UXEKTNMQSA-N
SMILES:
OC[C@H]1O[C@H]([C@@H]([C@H]([C@@H]1O)O)O)C1=C(O)C(C(=C(C1=O)C(=O)/C=C/c1ccc(cc1)O)O)(O)[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O

Properties

Complexity:
1160  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
10  
Defined Bond Stereocenter Count:
2  
Exact Mass:
612.169g/mol
Formal Charge:
0
Heavy Atom Count:
43  
Hydrogen Bond Acceptor Count:
16  
Hydrogen Bond Donor Count:
12  
Isotope Atom Count:
0
Molecular Weight:
612.537g/mol
Monoisotopic Mass:
612.169g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
295A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.5  

Literature

Title Journal
Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation. Phytomedicine : international journal of phytotherapy and phytopharmacology 20140215
Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption. Brain research 20120914
Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120815
Effects of hydroxy safflower yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 20120601
The effects of hydroxysafflor yellow A on blood pressure and cardiac function. Journal of ethnopharmacology 20120215
Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. Journal of ethnopharmacology 20120131
Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury. Biological & pharmaceutical bulletin 20120101
Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling. The American journal of Chinese medicine 20120101
Inhibitory effects of hydroxysafflor yellow A on the formation of advanced glycation end products in vitro. Biological & pharmaceutical bulletin 20120101
Hydroxysafflor yellow A protects PC12 cells against the apoptosis induced by oxygen and glucose deprivation. Cellular and molecular neurobiology 20111101
[Studies on pharmacokinetics of hydroxysafflor yellow A in Carthamus tinctorius and its compound preparation in rat]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20110801
Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. European journal of pharmacology 20110625
Identification and mapping of a novel hydroxysafflor yellow A (HSYA) biosynthetic gene in Carthamus tinctorius. Biochemical genetics 20110601
[Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20110601
[HPLC determination of four components in Tibetan medicine Dangzuo of different Tibetan regions]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20110401
[Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS]. Yao xue xue bao = Acta pharmaceutica Sinica 20110201
A strategy for detecting optimal ratio of cardioprotection-dependent three compounds as quality control of guan-xin-er-hao formula. Journal of ethnopharmacology 20110127
Identification of the major constituents in Xuebijing injection by HPLC-ESI-MS. Phytochemical analysis : PCA 20110101
Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A. International journal of nanomedicine 20110101
The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice. Phytotherapy research : PTR 20101201
Neuroprotective effects of hydroxysafflor yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors. Neurochemical research 20100901
[Simultaneous determination of multicomponent in Xuefuzhuyu granule with different UV-wavelength by HPLC]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20100801
Hydroxysafflor Yellow A suppresses thrombin generation and inflammatory responses following focal cerebral ischemia-reperfusion in rats. Bioorganic & medicinal chemistry letters 20100715
[Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats]. Yao xue xue bao = Acta pharmaceutica Sinica 20100701
Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats. Journal of ethnopharmacology 20100504
The mechanisms for enhanced oral absorption of hydroxysafflor yellow A by chuanxiong volatile oil. Planta medica 20100501
Effects of hydroxysafflor yellow A on the experimental traumatic brain injury in rats. Journal of Asian natural products research 20100301
Effects of hydroxysafflor yellow A in the attenuation of MPTP neurotoxicity in mice. Neurochemical research 20100101
Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits. BMC neuroscience 20100101
[Research on technological process of two-pot countercurrent extraction of hydroxysafflor yellow A]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20091101
Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers. Journal of ethnopharmacology 20090730
[Effects of hydroxy safflor yellow A on blood vessel and mRNA expression with VEGF and bFGF of transplantation tumor with gastric adenocarcinoma cell line BGC-823 in nude mice]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20090301
Effect of Guanxin No.2 decoction on gene expression in different areas of the myocardial infarcted heart of rats using microarray technology. The Journal of pharmacy and pharmacology 20090201
Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia. Vascular pharmacology 20090101
A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of hydroxysafflor yellow A in human plasma: application to a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081201
[Quality evaluation of Flos Carthami]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20081101
Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats. Phytotherapy research : PTR 20080801
Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax. Journal of cardiovascular pharmacology 20080801
Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats. Archives of pharmacal research 20080801
Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats. International journal of pharmaceutics 20080624
[Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia]. Yao xue xue bao = Acta pharmaceutica Sinica 20080601
[Hydroxysafflor yellow A up-regulates HIF-1alpha via inhibition of VHL and p53 in Eahy 926 cell line exposed to hypoxia]. Yao xue xue bao = Acta pharmaceutica Sinica 20080501
Characterization of C-glycosyl quinochalcones in Carthamus tinctorius L. by ultraperformance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Rapid communications in mass spectrometry : RCM 20080401
Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clinical and experimental pharmacology & physiology 20080201
Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. The Journal of pharmacy and pharmacology 20080101
Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action. Pharmacology 20080101
Simultaneous determination of hydroxysafflor yellow A and ferulic acid in rat plasma after oral administration of the co-extractum of Rhizoma chuanxiong and Flos Carthami by HPLC-diode array detector. Biomedical chromatography : BMC 20070801
Preparation of the traditional Chinese medicine compound recipe Shuxiong sustained-release capsules by multiparticulate time-controlled explosion technology. Die Pharmazie 20070501
Determination of hydroxysafflor yellow A in rat plasma and tissues by high-performance liquid chromatography after oral administration of safflower extract or safflor yellow. Biomedical chromatography : BMC 20070301
[Determination of safflor yellow A by RP-HPLC and resources quality comparison in Carthamus tinctorius]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20060801
[Preparation of Shuxiong micropellets by centrifugal granulation technology]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20060701
Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs. Planta medica 20060401
Simultaneous determination of components in preparation Naodesheng injection by high performance liquid chromatograph-atmospheric pressure chemical ionization mass spectrometry (HPLC-MS/APCI). Chemical & pharmaceutical bulletin 20060401
[Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats]. Yao xue xue bao = Acta pharmaceutica Sinica 20051201
Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neuroscience letters 20050923
Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms. Journal of Asian natural products research 20050801
The subchronic toxicity of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal injections in rats. Toxicology 20041015
[Protective effect of hydroxysafflor yellow A against rat cortex mitochondrial injuries induced by cerebral ischemia]. Yao xue xue bao = Acta pharmaceutica Sinica 20041001
[Establishment of chromatographic fingerprint and quality assessment of Carthamus tinctorius L. by high performance liquid chromatography]. Yao xue xue bao = Acta pharmaceutica Sinica 20040301
[Study on distribution of safflor yellow A in tissues of mice]. Yao xue xue bao = Acta pharmaceutica Sinica 20040301
Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Planta medica 20030501
[Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor]. Yao xue xue bao = Acta pharmaceutica Sinica 20020901

Related Products

© 2019 Angene International Limited. All rights Reserved.